JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

JPM

305.35

+0.44%↑

BAC

52.82

-0.28%↓

WFC

86.83

-0.14%↓

MS

165.1

-0.46%↓

AXP

361.54

+0.04%↑

Search

Walker & Dunlop Inc

Uždarymo kaina

SektoriusFinansų sektorius

82.98 -2.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

82.35

Max

85.31

Pagrindiniai rodikliai

By Trading Economics

Pajamos

30M

33M

Pardavimai

59M

296M

P/E

Sektoriaus vid.

26.346

27.54

Dividendų pajamingumas

3.08

Pelno marža

11.191

Darbuotojai

1,399

EBITDA

43M

122M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+11.94% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.08%

3.88%

Kitas uždarbis

2025-11-06

Kitas dividendų mokėjimo data

2025-12-05

Kita Ex Dividend data

2025-11-21

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

337M

2.9B

Ankstesnė atidarymo kaina

85.55

Ankstesnė uždarymo kaina

82.98

Naujienos nuotaikos

By Acuity

50%

50%

212 / 529 reitingas Finance

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Walker & Dunlop Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-28 23:50; UTC

Karštos akcijos

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

2025-10-28 23:25; UTC

Uždarbis

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

2025-10-28 23:18; UTC

Uždarbis

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

2025-10-28 22:20; UTC

Uždarbis

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

2025-10-28 22:13; UTC

Uždarbis

Wal-Mart de Mexico Net Profit Falls in 3Q

2025-10-28 21:38; UTC

Uždarbis

Correction to Visa Sales Jump Article

2025-10-28 21:17; UTC

Uždarbis

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

2025-10-28 21:07; UTC

Uždarbis

Visa Sales Jump as Consumers Keep Spending -- Update

2025-10-28 21:02; UTC

Uždarbis

Mondelez Tempers Outlook as Costs Rise

2025-10-28 23:51; UTC

Rinkos pokalbiai

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

2025-10-28 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

2025-10-28 23:02; UTC

Uždarbis

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

2025-10-28 23:01; UTC

Uždarbis

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

2025-10-28 22:46; UTC

Uždarbis

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

2025-10-28 22:45; UTC

Uždarbis

SK Hynix 3Q Net KRW12.6T >000660.SE

2025-10-28 22:44; UTC

Uždarbis

SK Hynix 3Q Rev KRW24.44T >000660.SE

2025-10-28 22:43; UTC

Uždarbis

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

2025-10-28 22:42; UTC

Uždarbis

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

2025-10-28 22:40; UTC

Uždarbis

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

2025-10-28 22:40; UTC

Uždarbis

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

2025-10-28 22:20; UTC

Uždarbis

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

2025-10-28 22:02; UTC

Uždarbis

Review & Preview: Earnings Extravaganza -- Barrons.com

2025-10-28 21:42; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-10-28 21:42; UTC

Rinkos pokalbiai
Uždarbis

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

2025-10-28 21:20; UTC

Uždarbis

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

2025-10-28 21:19; UTC

Uždarbis

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

2025-10-28 21:18; UTC

Uždarbis

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Akcijų palyginimas

Kainos pokytis

Walker & Dunlop Inc Prognozė

Kainos tikslas

By TipRanks

11.94% į viršų

12 mėnesių prognozė

Vidutinis 96 USD  11.94%

Aukščiausias 97 USD

Žemiausias 95 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Walker & Dunlop Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

70.995 / 76.69Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

212 / 529 reitingas Finansų sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.
help-icon Live chat